Effect Of Power Breath Device On Arterial Blood Gases And Diaphragmatic Excursion After Valve Surgery

Heart Valve Diseases Clinical Trial

Official title:

Effect Of Power Breath Device On Arterial Blood Gases And Diaphragmatic Excursion After Valve Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06012474
• Other study ID #: 012/004209
• Status: Completed
• Phase: N/A
• Start date: January 1, 2022
• Est. completion date: October 15, 2022

Study information

• Verified date: August 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effect of power breath device on arterial blood gases, diaphragmatic excursion and the 6 min walk test after cardiac valve surgery.

Description:

No more studies have been done on the effect of IMT by power breath on valvular surgery, So, this study will see the effect of power breath device on arterial blood gases, diaphragmatic excursion and six minute walk test after valve surgery to know enhanced recovery protocols in valvular surgery that accelerate the functional recovery, minimize the length of the hospital stay and decrease cost of treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 15, 2022
• Est. primary completion date: May 15, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 25 Years to 35 Years

Eligibility

Inclusion Criteria:

• Female patients with valve surgery (valve replacement or repair with median sternotomy procedure).

• Age between 25 to 35 years old.

• BMI is between 18.5 to 24.5 kg/m2.

Exclusion Criteria:

The participants will be excluded if they meet one of the following criteria:

• Uncontrolled hypertension (systolic blood pressure>230 mm Hg and diastolic blood pressure>120 mm Hg)

• Patients with coronary artery disease or heart failure.

• Need for mechanical ventilation for >24 h or reintubation.

• Renal and hepatic disorders.

• Infected or unstable sternum.

• patient with pneumothorax after surgery.

• Metabolic disorders.

• Pregnant woman.

• Lactating mother.

• Smokers

• Stroke patient

Related Conditions & MeSH terms

• Heart Valve Diseases

Intervention

Other:
• Power breath plus
Power breath plus use a variable load calibrated spring. It can be adjusted from the lowest load setting (17cmH2O) when training began and increased as the patient breathing muscles adapt and become stronger (maximum load setting 274cmH2O). Use a comfortable chair, preferably straight-back so that the spine is straight at all times during the exercise. patients will be instructed to exhale calmly, followed by a maximal forced inspiration to total lung capacity using a mouthpiece and a nasal clip as an aid to prevent air leaks and will ask to make 10 breaths for 3 sets once daily for 7 days with 2min rest between sets
• Incrementing the training load
The resistance will be increased incrementally, based on the rate of perceived exertion (RPE) scored by the patient on the modified Borg Scale. If the RPE is less than 5, the resistance of the inspiratory trainer will be increased incrementally by 2cmH2O. The resistance will not change if the level of perceived exertion is rated from 6 to 8, and the resistance will be decreased by 1 to 2 cmH2O if the level of perceived exertion is rated 9 or 10.
• Diaphragmatic breathing exercises
Training by using incentive spirometer: Loosen any tight clothing, especially around neck. Each patient will be instructed to sit upright with placing incentive spirometer at the same level of his mouth to promote optimal lung expansion while using the spirometer. The patient will be instructed to exhale letting all the breath out. patient will asked to close the lips around the mouthpiece of the spirometer. patient will be instructed to inhale slowly, breathing in until unable to do any more, this would raise the balls to the top of the column. patient will be asked to hold the breath as long as possible (at least five seconds) then exhale slowly. Session will be in the form of 30 times in sets, each set consist of 5-6 repetitions with rest 1 minute between sets. Intensity of exercise will be increased by increasing time of session, time of holding the breath and numbers of repetitions according to patient's status.

Locations

Country	Name	City	State
Egypt	Outpatient clinic faculty of physical therapy cairo university	Dokki

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessing the change in diaphragmatic excursion	By using Ultrasonography (Aloka prosound 4000, made in Japan) that will be used to assess diaphragmatic excursion. Diaphragmatic excursion is measured 3 times :at baseline before surgical intervention, second day after surgery (before the training program) and after 7 days of training program for all patient in the two groups. Diaphragmatic excursion was measured during deep breathing while the patient in semi-recumbent position on a comfortable bed using ultrasonography.	within 24 hours after 1 week of intervention
Primary	Assessing the change in Arterial Blood gases	Arterial blood gases are measured at baseline before surgical intervention, second day after surgery (before the training program) and after 7 days of training program for all patient in the two groups and can be obtained by direct arterial puncture most usually at the wrist (radial artery), femoral and brachial artery. An arterial blood sample (2 to 3 ml) will be collected.	within 24 hours after 1 week of intervention
Primary	Assessing the change in capacity to perform daily activities	by using the The 6-min walk test (6MWT) is a submaximal functional test indicative of the capacity to perform daily activities, patients will be asked to walk along a 30-m, flat and straight hospital corridor. Encouragement will be offered every minute, so that subjects will walk as far as possible. Symptom-limited interruptions (dyspnea, skeletal muscle pain, angina, dizziness) will allowed, though patients will be invited to resume walking as soon as possible. Most tests will be supervised by a physical therapist. Distance will be recorded in meters. Subjective dyspnea will quantified according to Borg Scale, ranging from 0 (no dyspnea) to 10 (severe dyspnea).	within 24 hours after 1 week of intervention